Clinical Meaningful Benefit Responder Rate7.91 Point Average rVCSS Improvement for the Clinically Meaningful Benefit Responder Cohort75% ...

The acquisition of ProgenaMatrix and revyve Antimicrobial Wound Gel reflects the Company's continued commitment to building a diverse portfolio of complementary wound care products that enable BioStem ...

BioStem expects to finalize definitive agreements within 60 days following customary due diligence. The transaction is subject to regulatory approvals and Board consent. BioStem and ProgenaCare will ...

Organogenesis Pleased to Lead Collaborative Effort to Support Data-Driven Policy on Local Coverage DeterminationCANTON, Mass., Nov. 15, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: ORGO), a leading regenerative ...

Report with market evolution powered by AI - The global wound care market size is estimated to grow by USD 6.95 billion from ...

Royalty-free licenses let you pay once to use copyrighted images and video clips in personal and commercial projects on an ongoing basis without requiring additional payments each time you use that ...

Adam Mence, Senior Brand Manager at L&R Medical UK, discusses the challenges of lower limb wound management and the benefits of driving evidence-based and self-care interventions Lower limb ulceration ...

A: Although popular perception may seem to indicate otherwise, current data is not sufficient to conclude that pressure ulcer rates at long-term care facilities are higher than those of hospitals.